Rabbit Polyclonal PARP8 antibody. C-terminal. Suitable for IHC-P, WB and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human Protein mono-ADP-ribosyltransferase PARP8.
pH: 7.4
Preservative: 0.05% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 49% PBS
IHC-P | WB | |
---|---|---|
Human | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/50.00000 - 1/200.00000 | Notes Perform heat-mediated antigen retrieval before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/200.00000 - 1/1000.00000 | Notes - |
Mono-ADP-ribosyltransferase that mediates mono-ADP-ribosylation of target proteins.
Protein mono-ADP-ribosyltransferase PARP8, ADP-ribosyltransferase diphtheria toxin-like 16, Poly [ADP-ribose] polymerase 8, ARTD16, PARP-8, PARP8
Rabbit Polyclonal PARP8 antibody. C-terminal. Suitable for IHC-P, WB and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human Protein mono-ADP-ribosyltransferase PARP8.
pH: 7.4
Preservative: 0.05% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 49% PBS
PARP8 also called Poly (ADP-ribose) polymerase family member 8 is a protein with a molecular mass of about 75 kDa. It belongs to the PARP family involved in catalyzing the transfer of ADP-ribose units from NAD+ to target proteins. PARP8 is found in various tissues including the brain liver and lungs. It plays a role in protein interactions mediating cellular processes and signaling.
Four distinct processes involve PARP8's actions in regulating transcription processes genome stability and DNA damage response. PARP8 may interact in complexes that further influence cellular responses to stress. It manages chromatin structure through poly-ADP-ribosylation affecting gene expression and cellular resilience against genotoxic stressors.
A couple of critical pathways engage PARP8's role in managing cellular equilibrium. The DNA damage response (DDR) pathway includes PARP8 collaborating with proteins like ATM and ATR which are involved in sensing DNA damage and promoting repair mechanisms. Additionally the transcriptional regulation pathway involves PARP8 affecting gene expression by modulating chromatin structure and interacting with transcription factors.
Several pathological conditions implicate PARP8 through its regulatory functions in cellular stress responses. Cancer is notable where abnormal PARP8 activity could disrupt genome stability and facilitate tumor progression. Inflammatory diseases also show connections with PARP8 activity involving its interaction with other PARP family members like PARP1 modulating inflammatory responses. Alterations in these pathways may contribute to understanding disease mechanisms and therapeutic interventions.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Immunohistochemical analysis of paraffin-embedded Human colon cancer tissue labeling PARP8 with ab200395 at 1/40 dilution.
All lanes: Western blot - Anti-PARP8 antibody - C-terminal (ab200395) at 1/200 dilution
All lanes: Hela cell lysate at 40 µg
Developed using the ECL technique.
Predicted band size: 95 kDa
Exposure time: 3min
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com